Trials / Completed
CompletedNCT00547573
Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection
A Multinational, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil Administered "On Demand" to Asian Men With Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 367 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to determine if tadalafil works better than placebo for Asian men having trouble getting or keeping an erection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tadalafil | 10 mg tadalafil tablet taken by mouth as needed for 12 weeks not more than once a day |
| DRUG | tadalafil | 20 mg tadalafil tablet taken by mouth as needed for 12 weeks not more than once a day |
| DRUG | placebo | placebo tablet taken by mouth as needed for 12 weeks not more than once a day |
Timeline
- Start date
- 2003-04-01
- Completion
- 2003-12-01
- First posted
- 2007-10-22
- Last updated
- 2007-10-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00547573. Inclusion in this directory is not an endorsement.